The global coronary stents market size is poised to reach the market value of over $16.88 billion by 2025 and market registering growth at a CAGR of around 7% from 2018 to 2025.
The stent is a small elastic tube like mesh which is made up of materials such as cobalt alloy or stainless steel. Stents implantation is on small balloons and opened inside the artery to give support to the vessel wall and reinstate blood flow. Stenting does not involve any major incision as compared to coronary artery bypass; hence, patients are more comfortable with stents which is driving the market of coronary stents.. A coronary stents is used in a procedure called percutaneous coronary intervention (PCI). According to recent studies, coronary stents are used in more than 90% of PCI procedures. Stents are mainly used to reduce angina (chest pain) and have been shown to improve durability and decrease undesirable events in an acute myocardial infarction. The treatment for coronary heart disease includes balloon angioplasty, pharmaceuticals, and stenting of coronary artery bypass grafting. Coronary stents also pose lower complications and health risks to the patients post surgery and shown better recovery compared to coronary bypass surgery.
The key factors driving the growth of coronary stents market is the alarming rise in the prevalence of cardiovascular diseases globally According to American Heart Association (AHA), cardiovascular diseases claim more lives than cancer and chronic lower respiratory diseases combined each year. Coronary heart disease is the leading cause of mortality in the U.S. attributable to cardiovascular diseases followed by stroke, heart failure, hypertension and other diseases. Other factor driving the market include developing health infrastructure, lifestyle disease, increasing geriatric population, profound increase in healthcare spending and healthcare coverage, subsequent growth in the number of percutaneous coronary intervention (PCI) procedures, advanced medical technologies and procedure, full-fledged demographic shift toward the aging of society and the development of information and communication technologies (ICT). Growing funding and investment by government for the research and development of efficient and effective stents will soar the demand for coronary stents market during the forecast period. Favorable reimbursement policies have shown to increase the adoption of coronary stents in countries such as U.S., Canada, India and U.K. For instance, the government in India subsidized the prices of drug eluting and bare metal stents in India to drive the adoption of stents in the country.
However, there are few complications post implementation of stents such as blood clots and infections in the stent sites. Blood clots and blockage are the most common which can be prevented by medicines such as aspirin and anti-platelets. Thus, there is a constant need for novel and innovative advancements in the market. Some of the areas of improvement include accuracy of the stents, enhancement in the work flow and procedure and reduction in error. Development of biodegradable polymer stents, bioresorbable stents, scaffolds and felicitation of minimally invasive procedures trends will drive the market for coronary stents during the forecast period.
Among all coronary stents types, both bare metals and drug eluting stent (DES) are extensively adopted in by patients and preferred by healthcare practitioners. Currently, drug eluting stents held the largest share in the global coronary stents market as it is considered as the gold standard treatment and will continue to exhibit strong growth during the forecast period. Drug eluting stents hold 80% of the market and is promoted by many healthcare professionals due to efficacy and benefits over other procedures. Moreover, with technological progress these stents have improved and reflected additional reduction in stent thrombosis. Using DES in stenting offers improved outcomes for patients with CAD treated with percutaneous coronary intervention (PCI). Bio-absorbable stents is projected to grow at a exponential rate during the forecast period. Bio-absorbable or Bioresorbable stents were introduced as an alternation owing to growing concerns of presence of stents for lifetime or until surgically eliminated. New product approvals and its benefits will surge the demand for these stents in global coronary stents market.
In terms of application, the global coronary stents market is segmented into angina and myocardial infarction. Angina held the largest share in this segment. Approximately, 80% of the total sales of coronary stents is generated by its application in angina. This application segment is expected to remain dominant throughout the forecast period owing to constantly rising target patient population across the world. Myocardial infarction accounted for the lower market share owing to smaller adoption of the device in this application. Lower adoption of this device would result in smaller revenue share throughout the forecast period.
The market research study on "Coronary Stents Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025”, offers a detailed insights on the global coronary stents market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. Information about porter's five forces analysis is also covered under the report scope. The report provides insights on global coronary stents market, its type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global coronary stents market size and volume, and segment markets by type, application, and geography along with the information on companies operating in the market. The coronary stents market analysis is provided for major regional markets including North America, Europe, China, Southeast Asia, Japan, India and rest of world followed by major countries.
The coronary stents market has high demand in North America region in 2017 and is anticipated to dominate the market during forecasted period. As per stroke association, approximately 1 million Americans each year are affected by stokes. Solitarily in the U.S., the financial drain of stroke is valued at $34 billion annually, which includes the expenditure on health care services, prescriptions, and reduced output. The ASA has put up great effort to transform the existing healthcare systems and patients worldwide by collaborating with other countries, governments and international cardiac societies.. Countries in this region have classic healthcare system, well planned program for compensation, and rise in number of population held a significant share in coronary stent market, worldwide. The new development in bio-absorbable stents with latest trends in growing popularity has been observed in this region. Asia Pacific is the second largest region and fastest growing as compared to others. China is the largest Asia-Pacific market for coronary stents. China has the largest population, with stroke one of the leading cause for death and claiming 1.6 million lives annually. China experiences similar stroke risk factors as compared to Western nations. Furthermore, China has identified specific geographic areas where the impermanence associated with stroke is 50% high than other regions in the country. Furthermore, growing healthcare infrastructure and target population in the countries like India, Japan, and Indonesia will further drive the market. Growing medical tourism in the region will further generate demand for coronary stents in the region. In China and India, the coronary stents market is increasing due to economic developments and rebuild of government. For example, a inclusive tax system and Goods and Services Tax (GST) in India avoid the effect of cascading tax, which helps both consumers and manufacturers to save tax. The players profiled in the report include Abbott Vascular, Medtronic, Boston Scientific, B. Braun Melsungen AG, Biotronik SE & Co. KG, Terumo, Stentys SA, Becton Dickinson and Co., Cook Group, SMT and Micro Port among others. Companies are engaging into mergers & acquisition and strategic alliances with universities and academic institutes to develop innovative products and maintain competitive edge over other competitors.
Market By Type
Market By Application
Market By Geography
According to Acumen Research and Consulting, the global Botulinum Toxin market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 7.5 billion by 2026. The imperative quality needs and fresh apps are sustaining competition in the worldwide industry of botulinum toxins. Most businesses invest in studies to identify fresh apps which c
Introduction According to Acumen Research and Consulting, the global market of Surgical Instrument Tracking Systems is expected to grow at noteworthy CAGR around 18.6 % throughout the forecast period and reach around US$ 500 million by 2026. Surgical instruments have long been accessible for use in healthcare. Systems for the mo
Introduction According to Acumen Research and Consulting, the global Aesthetic Medicine market is expected to grow at noteworthy CAGR around 8.5 % throughout the forecast period and reach around US$ 16.3 billion by 2026. Aesthetic Medicines is a clinical subspecialty and field for scientific research that includes all kinds of m
Introduction: Viscosupplementation is a treatment that aids in diminishing joint agony and improves the practical state of the osteoarthritic joint. It includes the infusion of a thick liquid called hyaluronate into the knee. Hyaluronic corrosive is found in the gooey synovial liquid that greased up the ligament surfaces and shields the joint from stun. This corrosive is a versatil
Introduction: Smart home healthcare is intended to help in treatment determination, care in the home. It helps in improving the correspondence between the parental figures and healthcare suppliers. Also, numerous wellbeing conditions, particularly incessant illnesses, could be checked and treated in a home outfitted with fundamental smart home items. The global smar
Introduction: The global hyaluronic acid market size is expected to reach 11.07 billion by the end of year 2026. The market is estimated to grow at a CAGR of 6.6% over the forecast period 2019 to 2026. Hyaluronic acid, otherwise called hyaluronan, is a reasonable, gooey substance that is normally delivered by your body. Its biggest measures are found in you